Back
Natera 10K Form
Sell
34
NTRA
Natera
Last Price:
$152.50
Seasonality Move:
13.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NTRA News And Ratings
See the #1 stock for the next 7 days that we like better than NTRA
NTRA Financial Statistics
Sales & Book Value
| Annual Sales: | $1.7B |
|---|---|
| Cash Flow: | $22.6M |
| Price / Cash Flow: | 271.47 |
| Annual Sales: | $9.12 |
| Price / Book: | 17.42 |
Profitability
| EPS (TTM): | -1.47000 |
|---|---|
| Net Income (TTM): | $-189.8M |
| Gross Margin: | $1B |
| Return on Equity: | -19.19% |
| Return on Assets: | -11.91% |
Natera Earnings Forecast
Key Natera Financial Ratios
-
The Gross Profit Margin over the past 12 years for NTRA is 60.30%.
-
The Selling, General & Administrative Expenses for NTRA have been equal to 49.58% of Gross Profit Margin.
-
The Research & Development expenses have been 23.82% of Revenue.
-
The Net Earning history of NTRA is -11.22% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 6 years.
Natera Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NTRA |
| CUSIP: | 632307 |
| Website: | natera.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 3.87 |
| Quick Ratio: | 3.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |